BIIB

Biogen Idec Inc. News Headlines

$321
*  
5.94
1.89%
Get BIIB Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
10/31/2014 6:00:00 AM - TheStreet


Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14)
10/31/2014 5:46:00 AM - Seeking Alpha


Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape
10/30/2014 9:25:00 AM - Zacks.com


Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary
10/30/2014 8:00:43 AM - Zacks.com


Amgen’s operating margins have been flat despite revenue growth
10/29/2014 5:00:00 PM - Market Realist


Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog
10/29/2014 3:05:00 PM - Zacks.com


Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog
10/29/2014 2:00:00 PM - Zacks.com


Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog
10/29/2014 1:00:00 PM - Zacks.com


One More Time: The Genzyme Contingent Value Right
10/29/2014 10:15:00 AM - Seeking Alpha


The Medicines Company (MDCO) Jumps: Stock Gains 16.5% - Tale of the Tape
10/29/2014 9:25:00 AM - Zacks.com


Third Point Partners ups stake in Amgen
10/29/2014 9:00:00 AM - Market Realist


Gilead (GILD) Posts Weak Earnings; Stock Falls 4% After-Hours - Stocks in the News
10/28/2014 11:58:12 PM - Zacks.com


Biogen Decline Over PML Tied To Tecfidera, Offers Investors A Lower Entry Point
10/28/2014 4:25:00 PM - Seeking Alpha


Pfizer Q3 Earnings Top Estimates Despite Generic Pressure - Analyst Blog
10/28/2014 4:10:00 PM - Zacks.com


Sarepta Slumps as Eteplirsen NDA Submission Gets Delayed - Analyst Blog
10/28/2014 2:22:00 PM - Zacks.com


Amgen Beats on Q3 Earnings & Revenues, Ups View Again - Analyst Blog
10/28/2014 9:10:00 AM - Zacks.com


Sarepta Slumps: SRPT Plunges 32.5% in Session - Tale of the Tape
10/28/2014 8:49:00 AM - Zacks.com


Are XLV And The Health Care Sector Overpriced?
10/27/2014 6:09:00 PM - Seeking Alpha


Biogen: Nothing To Worry About
10/27/2014 4:24:00 PM - Seeking Alpha


Merck Tops on Q3 Earnings, Patent Expiries Hit Revenues - Analyst Blog
10/27/2014 11:00:00 AM - Zacks.com


A safe route into the biotech sector
10/27/2014 10:00:00 AM - InvestorsObserver


Allergan Beats on Earnings, Revenues; Valeant Raises Offer - Analyst Blog
10/27/2014 9:52:00 AM - Zacks.com


Is Biogen Idec Inc. in Trouble?
10/27/2014 9:07:20 AM - Motley Fool


3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
10/27/2014 8:03:02 AM - Motley Fool


Biogen Falls on Concerns Regarding Tecfidera Sales and PML Case - Analyst Blog
10/24/2014 4:39:00 PM - Zacks.com